Modern owners increasingly perceive pets as family members and buy food for them similar to their own food. However, the ...

HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial ...

Astellas Pharma (($ALPMF)) announced an update on their ongoing clinical study. Study Overview: Astellas Pharma, in collaboration with Iota ...

Modern obstetric advances have improved labor management with pain medication integration, yet gynecologic pain management ...

It was during peak Marie Kondo that I decided to enforce order on my kitchen cupboards. I scrubbed, I jettisoned produce that ...

Allergan Aesthetics, an AbbVie company , today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first ...

On the corporate side, during the quarter, we completed our merger or reverse merger, if you like, with BerGenBio, thereby also uplisting from Euronext grows to Oslo Børs main markets. And we also ...

UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX (R) (bimekizumab-bkzx) in adults with active ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 ...

The Gold Coast Child and Youth Mental Health Service entered an internal awards competition for its training of staff to ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva ® ...